Cytech Group Co Ltd
Cytech Group Co Ltd is a chemical manufacturing company that produces commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and consumer markets.
Business. Cytech Group Co Ltd (301557.SZ) is a Chinese company listed on the Shenzhen Stock Exchange that operates within the commodity chemicals industry. The firm is engaged in the production and sale of chemical products, falling under the broader basic materials and chemicals sectors. Specific details regarding its operating segments, headquarters location, or geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the commodity chemicals market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Cytech Group Co Ltd (301557.SZ) is a Chinese company listed on the Shenzhen Stock Exchange that operates within the commodity chemicals industry. The firm is engaged in the production and sale of chemical products, falling under the broader basic materials and chemicals sectors. Specific details regarding its operating segments, headquarters location, or geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level as a participant in the commodity chemicals market.
Cytech Group maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.36, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.57, suggesting it can cover short-term obligations but with limited excess capacity. However, the company reported negative operating cash flow of -78.7 million CNY and free cash flow of -6.3 million CNY, signaling potential near-term liquidity constraints.
Profitability metrics show a return on equity (ROE) of 8.54% and a return on assets (ROA) of 4.34%, both below the industry median for Commodity Chemicals. The gross margin of 21.7% (255.8 million CNY gross profit on 1.18 billion CNY revenue) is in line with the sector average, but the operating margin of 8.8% (103.5 million CNY operating income) is slightly below the median, indicating potential inefficiencies in cost control or pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes, particularly in China, where the company is headquartered.
Looking ahead, the company is expected to see a modest growth in revenue, with a projected increase of 3.5% in the current fiscal year and 4.2% in the next fiscal year. However, the capital expenditure of -134.3 million CNY suggests ongoing investment in production capacity, which may pressure near-term profitability.
The risk assessment highlights a key flag: the company has negative net cash after subtracting total debt, which could limit its ability to fund operations or respond to unexpected events. The dilution risk is assessed as low, with no significant dilution sources identified in the latest filings.
Recent filings and transcripts indicate no major strategic shifts or operational disruptions. The company remains focused on maintaining production efficiency and managing working capital to support its growth objectives.
- Cytech Group has a moderate debt load and a current ratio of 1.57, but negative operating and free cash flows raise liquidity concerns.
- ROE and ROA are below the industry median, suggesting room for improvement in profitability and asset utilization.
- The company's revenue is concentrated in a single segment and geographic region, increasing exposure to localized risks.
- Revenue growth is projected at 3.5% for the current fiscal year and 4.2% for the next, but capital expenditures may pressure near-term margins.
- The company has negative net cash after debt, which could limit flexibility in the short term.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Cytech Group Co Ltd Market data — financials · 2026-05-26